Pazopanib as a new culprit in neutrophilic eccrine hidradenitis

Fang-Ying Wang¹, Wei-Ti Chen¹, Meng-Han Shen¹, Wen-Hung Chung², Chun-Bing Chen^3
1 Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung; College of Medicine, Chang Gung University, Taoyuan, Taiwan
² Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospitals, Xiamen, China; Cancer Vaccine and Immune Cell Therapy Core Laboratory; Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital, Linkou, Taiwan
³ Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung; College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospitals, Xiamen, China; Cancer Vaccine and Immune Cell Therapy Core Laboratory; Immune-Oncology Center of Excellence, Chang Gung Memorial Hospital, Linkou; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan

Correspondence Address:
Dr. Chun-Bing Chen
Department of Dermatology, Chang Gung Memorial Hospitals, Taipei, Linkou and Keelung; College of Medicine, Chang Gung University, Taoyuan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Linkou and Keelung; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ds.ds_6_19